e-learning
resources
Virtual 2020
Pre-Congress Content
Treatment of obstructive sleep apnoea and its effects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
KaLinix® in the treatment of Obstructive Sleep Apnea-Hypopnea syndrome (OSAHS).
S. Esmaili (Madrid, Spain), G. Vargas Centanaro (Madrid, Spain), J. Rodríguez Hermosa (Madrid, Spain), J. Álvarez-Sala (Madrid, Spain), N. Raissouni (Madrid, Spain), M. Calle Rubio (Madrid, Spain)
Source:
Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Session:
Treatment of obstructive sleep apnoea and its effects
Session type:
E-poster session
Number:
2147
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Esmaili (Madrid, Spain), G. Vargas Centanaro (Madrid, Spain), J. Rodríguez Hermosa (Madrid, Spain), J. Álvarez-Sala (Madrid, Spain), N. Raissouni (Madrid, Spain), M. Calle Rubio (Madrid, Spain). KaLinix® in the treatment of Obstructive Sleep Apnea-Hypopnea syndrome (OSAHS).. 2147
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The study of small airways' function in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS).
Source: International Congress 2017 – Pathophysiological aspects of comorbid conditions in obstructive sleep apnoea
Year: 2017
The prevalence of Obstructive Sleep Apnea (OSA) in patients recovering from COVID-19
Source: Sleep and Breathing Conference 2021
Year: 2021
Obstructive sleep apnea in adults with Down syndrome
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016
Obstructive sleep apnea hypopnea syndrome in eldery patients
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014
Asthma and Obstructive Sleep Apnea Syndrome (OSAS)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Obstructive sleep apnea-hypopnea syndrome in patients with asthma
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Weight changes in patients with obstructive sleep apnoea syndrome (OSAS) before and after CPAP
Source: International Congress 2014 – Sleep disordered breathing: from children to the elderly
Year: 2014
Obstructive sleep apnoea/hypopnoea syndrome in adults with Down syndrome
Source: Breathe 2016; 12: e91-e96
Year: 2016
Obstructive sleep apnea syndrome and cardiometabolic disorders – Is there an association?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Obstructive sleep apnoea in patients with type 1 diabetes
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Obstructive sleep apnoea (OSA) in the elderly
Source: Eur Respir J 2002; 20: Suppl. 38, 575s
Year: 2002
Obstructive sleep apnoea (OSA) and hypothyroidism
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
A novel connection: Obstructive sleep apnoea and diabetic neuropathy
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Obstructive sleep apnea (OSA) in young and elderly patients – Does age matter?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015
Obstructive sleep apnoea syndrome
Source: Breathe 2009; 6: 122-123
Year: 2009
Respiratory function in patients with obstructive sleep apnea hypopnea syndrome
Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults
Year: 2014
Erythrocytosis in patients with obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014
Obstructive Sleep Apnea (OSA) Assessment in the elderly. Preliminary results.
Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer
Year: 2018
Obstructive sleep apnea and metabolic syndrome in 1,600 adult Japanease PSG cases.
Source: International Congress 2018 – Sleep and breathing control: phenotypes
Year: 2018
Obstructive sleep apnea syndrome (OSAS). Value of cardiovascular markers (CM) to detect arousals
Source: Eur Respir J 2003; 22: Suppl. 45, 272s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept